⚠️ Read This First – Not Medical Advice
This article summarizes findings from peer-reviewed studies. Psychedelics can strongly affect the nervous and cardiovascular systems. Nothing here substitutes for professional medical guidance.
☕ Why Coffee Enters the Conversation
Coffee’s primary active compound, caffeine, is a mild central-nervous-system stimulant. Coffee contains polyphenols and β-carbolines. These compounds show weak, reversible inhibition of monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B) in vitro (PMID 16423318). Because both ayahuasca and certain antidepressants depend on MAO modulation, this overlap matters.
🌿 Ayahuasca + Coffee: What the Data Say
The Mechanism
Ayahuasca combines DMT with β-carbolines such as harmine and harmaline that reversibly inhibit MAO-A (PMID 35664562). MAO-A inhibition allows DMT to remain active when taken orally.
The Concern
MAO-A inhibition means other MAO-interacting compounds—including caffeine—could in theory amplify blood-pressure or heart-rate increases. A published case report of hypertensive crisis under pharmaceutical MAOIs with high caffeine intake shows that risk. Even if ayahuasca’s inhibition is weaker and shorter-lived, the risk is still significant.
Best-Practice Consensus
- Before / after ceremonies: many facilitators and pharmacology reviews recommend avoiding caffeine for 2–3 days before and after (PMC7678905).
- During: abstain entirely. Combining a stimulant with an MAO-A inhibitor adds unnecessary physiological load and may heighten anxiety or nausea.
- If habitual drinker: taper rather than quit suddenly to avoid withdrawal headaches.
🍄 Psilocybin + Coffee: What’s Actually Known
Trial Protocols
Modern psilocybin studies by Johns Hopkins, NIH, and others offer specific guidance. They typically tell participants to keep their usual small morning coffee if they are habitual users. Participants should avoid extra caffeine for 6 hours before and after dosing (PMID 39073047). The goal is stable physiology, not full abstinence.
Research Gaps
There are no controlled human trials directly comparing psilocybin + caffeine versus psilocybin alone. An OSF experiment was preregistered. It is titled “The Effects of a Low Psilocybin Dose With and Without Caffeine”. The results have not yet been published.
Observational Findings
Naturalistic-use surveys report about 15% of users drink coffee during psilocybin experiences (PMID 37531611). No outcome difference has been confirmed.
Microdosing Context
Systematic reviews of microdosing trials note that caffeine is sometimes used as an active placebo, not a synergist (PMID 38249314). Evidence for cognitive or mood benefits from combining caffeine + sub-perceptual psilocybin doses is absent.
⚖️ Physiological and Safety Summary
| Variable | Coffee / Caffeine Effect | Psychedelic Context | Combined Consideration |
|---|---|---|---|
| Blood Pressure | ↑ (Transient) | Ayahuasca ↑ / Psilocybin ↑ modestly | Possible additive ↑ |
| Heart Rate | ↑ Slight to Moderate | ↑ Mild to Moderate | Additive risk for tachycardia |
| MAO Activity | Weak reversible inhibition | Ayahuasca = strong temporary MAO-A block | Theoretical interaction |
| Anxiety / Arousal | May increase | Can increase at onset | Avoid if prone to anxiety |
| Sleep Interference | Common after caffeine | Post-session sleep often light | Combine = less rest |
🧠 What We Know vs What We Don’t
| Well-Supported | Speculative / Unproven |
|---|---|
| Coffee mildly inhibits MAO-A/B in vitro | Caffeine changes ayahuasca subjective effects |
| Ayahuasca’s β-carbolines inhibit MAO-A in vivo | Coffee enhances psilocybin creativity or focus |
| Caffeine + MAOI → hypertension in case reports | Microdosing psilocybin + coffee is beneficial |
| Psilocybin trials limit caffeine around sessions | Any unique synergy between coffee and DMT / psilocybin |
🧭 Practical Takeaways
- Avoid caffeine on ayahuasca days; minimize several days before / after.
- For psilocybin sessions, keep only your normal small coffee—no extras.
- Microdosing: nothing proven; if anxious, go decaf.
- MAOI medications or heart conditions: absolutely consult a physician first.
- Research gap: controlled human studies on caffeine-psychedelic interactions are still missing.
- Feel free to drink coffee once you are completely done with your ayahuasca experience.
Are you looking for a reliable (and legal) entheogenic retreat center?
Our friends over at Agape Church in Conroe, Texas have received traditional training by a Colombian medicine to properly and safely facilitate these sacred ayahuasca ceremonies. And, they have been safely facilitating psylocibin ceremonies for many years. Agape Church has served over 1,500 people since 2019. Participants have traveled from all over the country and world to attend their retreats.
Agape’s voice: “Agape Church is an interfaith spiritual community that welcomes individuals from all paths. We host
enriching spiritual retreats designed to foster personal growth, community connection, and a deeper
understanding of diverse spiritual traditions.
Celebrating diversity in all forms, Agape Church warmly welcomes everyone, inviting you to explore a deeper connection with your Soul, Mind, and Body, transcending boundaries of religion, race, and personal backgrounds.”
Agape Church is a registered 508c1a non-profit that has listed their listed entheogenic practices to legally facilitate these ceremonies. You can learn more about their location, retreats and more on their website: https://www.agape4smb.com
Read Part 2: ‘Ayahuasca Timing & Risks Guidelines’ HERE
Read Part 3: ‘Coffee + Psilocybin: Microdosing, Macrodosing & Neurochemistry’ HERE
📚 References
- Herraiz T. Life Sci. 2006 — “Monoamine oxidase inhibition by coffee.” PMID 16423318
- Berlowitz D et al. Front Pharmacol. 2022 — “β-Carboline MAO Inhibition.” PMID 35664562
- van der Hoeven MA et al. J Clin Psychopharmacol. 2014 — “Caffeine and tranylcypromine hypertension case.” PMID 24798537
- Ruffell JD et al. Front Pharmacol. 2020 — “Ayahuasca Pharmacology Review.” PMC7678905
- dos Santos RG et al. CNS Spectr. 2023 — “Safety and Therapeutic Effects of Ayahuasca.” DOI:10.1017/S1092852923000030
- Johnson MW et al. Psychopharmacology. 2008 — “Human Hallucinogen Safety Guidelines.” PMID 17985129
- Kuypers KP et al. Prog Neuropsychopharmacol Biol Psychiatry. 2024 — “Microdosing Psychedelics: Controlled Evidence.” PMID 38249314
- Front Psychiatry 2023 — “Naturalistic Psilocybin Use and Caffeine.” PMID 37531611



